APTUK Position Statement for DHSC PGD Update

The Association of Pharmacy Technicians UK (APTUK), as the professional leadership body for pharmacy technicians, welcome the positive outcome of the DHSC consultation supporting the enabling of registered pharmacy technicians to supply and administer medications under patient group directions.

This is a landmark moment for patient care and will ensure pharmacy technicians are able to safely expand access to pharmacy services in a pressured healthcare landscape. During the COVID-19 pandemic it was also evident that pharmacy technicians and their potential were not able to be fully utilised to support delivery of essential frontline pharmacy services, such as vaccination.

To practise using a PGD, healthcare professionals must have completed any training outlined in the PGD and have been deemed competent and authorised by the provider organisation. As registered profession, pharmacy technicians must also uphold pharmacy professional standards stipulated by the regulator the General Pharmaceutical Council, and complete continued professional development relevant for their area of practice and role.

APTUK acknowledge that initially the powers will apply in England, Wales & Scotland only. This is because pharmacy technicians in Northern Ireland are not currently registered, therefore the planned changes will not enable pharmacy technicians in Northern Ireland to use PGDs. APTUK are assured that once pharmacy technicians in Northern Ireland become registered and regulated, further amendments may be made to permit this.

With this announcement, APTUK have also released the first in a series of supportive documents to educate and support pharmacy technicians with their scope of practice with such developments and changes to legislation.

Read the full article here

Latest News

By BOPA Executive Committee on 1st August 2026

4 Weeks left to Nominate your BOPA Fellowship

4 Weeks left to nominate a BOPA Fellow for 2026. The BOPA Fellowship Scheme Policy has been updated for a clearer nomination and selection process including specific criteria for assessing the nominated individuals.…

Read article
By BOPA Executive Committee on 31st July 2026

Supporting awareness of occupational risks from hazardous medicinal products – BOPA and PASG

Dear BOPA Member, Every day, oncology pharmacy professionals play a vital role in ensuring patients receive safe and effective SACT. Whether preparing, dispensing, transporting or supporting the administration of hazardous…

Read article
By BOPA Executive Committee on 29th July 2026

Publication ALERT – Managing aseptic capacity pressures in systemic anti-cancer therapy services: A national mixed-methods evaluation of UK SACT board guidance implementation

BOPA Publication: Managing aseptic capacity pressures in systemic anti-cancer therapy services: A national mixed-methods evaluation of UK SACT board guidance implementation – Annette (Netty) Cracknell, Dharmisha Chauhan, Lisa Barrott, Emma…

Read article
By BOPA on 24th July 2026

Call for BOPA Award nominations – 1 week left!

It’s awards time – call for nominations! We have had lots of positive feedback from the introduction of the awards dinner at the annual conference, and we are now calling…

Read article